COVID-19: Oxford University to test vaccine response among children for first time



The University of Oxford has launched a study to assess the safety and immune response of the COVID-19 vaccine it has developed with AstraZeneca Plc in children for the first time. The new mid-stage trial will determine whether the vaccine is effective on people between the ages of 6 and 17.